Report cover image

ClearNote Health - Product Pipeline Analysis, 2023 Update

Publisher GlobalData
Published Apr 04, 2024
Length 28 Pages
SKU # GBDT18719563

Description

Summary


ClearNote Health (ClearNote) is a biotechnology company that develops non-invasive tests to detect pancreatic and ovarian cancer. The company utilizes a 5hmC-based proprietary technology platform to provide a deep understanding of the underpinnings of cancer development. ClearNote non-invasive liquid biopsy technologies detect changes in specific organs, identify biological activity and gene expression, improve therapy selection and safety monitoring and evaluate individual’s organ systems and biological functions. It also carries out research and development, clinical trials and tests. The company works in collaboration with leading research institutions and academic and pharmaceutical industry collaborators. It operates offices in San Diego and San Mateo, the US. ClearNote is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company ClearNote Health
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company

Table of Contents

28 Pages
ClearNote Health Company Overview
ClearNote Health Company Snapshot
ClearNote Health Pipeline Products and Ongoing Clinical Trials Overview
ClearNote Health – Pipeline Analysis Overview
ClearNote Health - Key Facts
ClearNote Health - Major Products and Services
ClearNote Health Pipeline Products by Development Stage
ClearNote Health Ongoing Clinical Trials by Trial Status
ClearNote Health Pipeline Products Overview
ClearNote Health Pancreatic Cancer Detection Test
ClearNote Health Pancreatic Cancer Detection Test Product Overview
ClearNote Health Pancreatic Cancer Detection Test Clinical Trial
Multi-Cancer Detection Test
Multi-Cancer Detection Test Product Overview
Non-Small Cell Lung Cancer Detection Test
Non-Small Cell Lung Cancer Detection Test Product Overview
Ovarian Cancer Detection Test
Ovarian Cancer Detection Test Product Overview
ClearNote Health - Key Competitors
ClearNote Health - Key Employees
ClearNote Health - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
ClearNote Health, Recent Developments
Mar 26, 2024: New Data Show ClearNote Health’s Epigenomic Platform Provides a Novel Tissue-Free, Liquid Biopsy-Based Approach to Identify Potential Predictive Biomarker Candidates to Radioligand Therapy Response in Patients With Pancreatic Neuroendocrine Tumors
Jan 30, 2024: Personalis and ClearNote Health Announce Partnership to Advance Epigenomic Technology
Jan 16, 2024: ClearNote Health Announces New Proprietary Approach for Predicting Immunotherapy Treatment Response in Non-Small Cell Lung Cancer Using Only Blood
May 08, 2023: Study validating ClearNote Health’s Avantect pancreatic cancer detection test published in the Journal Clinical Gastroenterology and Hepatology
Dec 21, 2022: Bluestar Genomics Advances to Commercial Phase, Rebrands as ClearNote Health
Nov 02, 2022: Bluestar Genomics presents positive results from validation study in pancreatic cancer detection at American Pancreatic Association (APA) Annual Meeting
Sep 12, 2022: Bluestar Genomics presents data on new applications of its epigenomic cancer detection platform
Jan 20, 2022: Bluestar Genomics presents positive results of its pancreatic cancer test performance evaluation at 2022 ASCO GI Cancers Symposium
Nov 08, 2021: Bluestar Genomics reports data on non-invasive pancreatic cancer test
Mar 31, 2021: Bluestar Genomics receives FDA breakthrough device designation for first-of-its-kind pancreatic cancer screening test
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: ClearNote Health Pipeline Products and Ongoing Clinical Trials Overview
Table 2: ClearNote Health Pipeline Products by Equipment Type
Table 3: ClearNote Health Pipeline Products by Indication
Table 4: ClearNote Health, Key Facts
Table 5: ClearNote Health, Major Products and Services
Table 6: ClearNote Health Number of Pipeline Products by Development Stage
Table 7: ClearNote Health Pipeline Products Summary by Development Stage
Table 8: ClearNote Health Ongoing Clinical Trials by Trial Status
Table 9: ClearNote Health Ongoing Clinical Trials Summary
Table 10: ClearNote Health Pancreatic Cancer Detection Test - Product Status
Table 11: ClearNote Health Pancreatic Cancer Detection Test - Product Description
Table 12: ClearNote Health Pancreatic Cancer Detection Test - EpiDetect Study: Clinical Validation of a Pancreatic Cancer Detection Test in New-onset Diabetes Patients
Table 13: ClearNote Health Pancreatic Cancer Detection Test - New Onset Diabetes Management for Earlier Detection of Pancreatic Cancer (NODMED)
Table 14: Multi-Cancer Detection Test - Product Status
Table 15: Multi-Cancer Detection Test - Product Description
Table 16: Non-Small Cell Lung Cancer Detection Test - Product Status
Table 17: Non-Small Cell Lung Cancer Detection Test - Product Description
Table 18: Ovarian Cancer Detection Test - Product Status
Table 19: Ovarian Cancer Detection Test - Product Description
Table 20: ClearNote Health, Key Employees
Table 21: ClearNote Health, Other Locations
Table 22: Glossary
List of Figures
Figure 1: ClearNote Health Pipeline Products by Equipment Type
Figure 2: ClearNote Health Pipeline Products by Development Stage
Figure 3: ClearNote Health Ongoing Clinical Trials by Trial Status

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us